<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T03:50:29Z</responseDate>
  <request identifier="oai:figshare.com:article/34024059" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34024059</identifier>
        <datestamp>2026-09-29T13:38:34Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Probiotic-Derived
Exopolysaccharides Enhance Mesenchymal
Stem Cell-Mediated Fibroblast Repair under Hyperglycemic Conditions</dc:title>
          <dc:creator>Mesude Bicer (22279266)</dc:creator>
          <dc:creator>Mert Akdur (25137270)</dc:creator>
          <dc:creator>Esra Battal (25137273)</dc:creator>
          <dc:creator>Fatma Sener (22279272)</dc:creator>
          <dc:creator>Irem Yilmaz (25137276)</dc:creator>
          <dc:creator>Özkan Fidan (22279278)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>supportive bioactive agent</dc:subject>
          <dc:subject>preliminarily characterized prior</dc:subject>
          <dc:subject>persistent oxidative stress</dc:subject>
          <dc:subject>oxidative stress levels</dc:subject>
          <dc:subject>mesenchymal stem cells</dc:subject>
          <dc:subject>mediated fibroblast repair</dc:subject>
          <dc:subject>improve tissue repair</dc:subject>
          <dc:subject>delayed tissue regeneration</dc:subject>
          <dc:subject>decreased fibroblast activity</dc:subject>
          <dc:subject>propidium iodide staining</dc:subject>
          <dc:subject>apoptotic cell death</dc:subject>
          <dc:subject>glucose conditions prior</dc:subject>
          <dc:subject>diabetic wound healing</dc:subject>
          <dc:subject>wound closure</dc:subject>
          <dc:subject>healing wounds</dc:subject>
          <dc:subject>diabetic microenvironment</dc:subject>
          <dc:subject>da staining</dc:subject>
          <dc:subject>subsequent cell</dc:subject>
          <dc:subject>cell viability</dc:subject>
          <dc:subject>like conditions</dc:subject>
          <dc:subject>hyperglycemic conditions</dc:subject>
          <dc:subject>strongest effect</dc:subject>
          <dc:subject>scratch assay</dc:subject>
          <dc:subject>relatively weaker</dc:subject>
          <dc:subject>regenerative responses</dc:subject>
          <dc:subject>potential agents</dc:subject>
          <dc:subject>plantarum &lt;/</dc:subject>
          <dc:subject>often lead</dc:subject>
          <dc:subject>mtt assay</dc:subject>
          <dc:subject>migration potential</dc:subject>
          <dc:subject>lactobacillus plantarum</dc:subject>
          <dc:subject>lactobacillus brevis</dc:subject>
          <dc:subject>l929 fibroblasts</dc:subject>
          <dc:subject>hyperglycemic microenvironment</dc:subject>
          <dc:subject>findings suggest</dc:subject>
          <dc:subject>examined whether</dc:subject>
          <dc:subject>eps fractions</dc:subject>
          <dc:subject>eps derived</dc:subject>
          <dc:subject>derived eps</dc:subject>
          <dc:subject>derived biomolecules</dc:subject>
          <dc:subject>conditioned medium</dc:subject>
          <dc:subject>closely associated</dc:subject>
          <dc:subject>chronic non</dc:subject>
          <dc:subject>brevis &lt;/</dc:subject>
          <dc:subject>based experiments</dc:subject>
          <dc:subject>bacterial exopolysaccharides</dc:subject>
          <dc:subject>attracted attention</dc:subject>
          <dc:subject>assessed using</dc:subject>
          <dc:description>Diabetic wounds are closely associated with persistent
oxidative
stress, decreased fibroblast activity, and delayed tissue regeneration
under hyperglycemic conditions. These pathological features particularly
complicate wound healing and often lead to chronic non-healing wounds.
Recently, mesenchymal stem cells (MSCs) and probiotic-derived biomolecules
have attracted attention as potential agents to improve tissue repair.
In this study, we examined whether the combination of adipose-derived
mesenchymal stem cell-conditioned medium (ADMSC-CM) and bacterial
exopolysaccharides (EPSs) could improve fibroblast responses under
diabetes-like conditions. EPSs were extracted from Lactobacillus plantarum and Lactobacillus
brevis, purified and preliminarily characterized prior
to subsequent cell-based experiments. To stimulate a diabetic microenvironment,
L929 fibroblasts were exposed to high-glucose conditions prior to
treatment with ADMSC-CM, purified EPSs, or their combination. Cell
viability, oxidative stress levels, apoptosis, and migration potential
were assessed using the MTT assay, DCFH-DA staining, acridine orange/propidium
iodide staining, and scratch assay, respectively. Interestingly, the
combination of ADMSC-CM with &lt;i&gt;L. brevis&lt;/i&gt;-derived EPS
showed the strongest effect. This treatment improved fibroblast viability
and wound closure under hyperglycemic conditions while significantly
reducing intracellular ROS levels and apoptotic cell death. EPS derived
from &lt;i&gt;L. plantarum&lt;/i&gt; also showed supportive effects,
but these regenerative responses were relatively weaker. Both EPS
fractions were found to be biocompatible at 1000 μg/mL. Overall,
these findings suggest that probiotic-derived EPS can enhance ADMSC-mediated
fibroblast repair in a hyperglycemic microenvironment and serve as
a supportive bioactive agent in diabetic wound healing.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acsomega.6c07182.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Probiotic-Derived_Exopolysaccharides_Enhance_Mesenchymal_Stem_Cell-Mediated_Fibroblast_Repair_under_Hyperglycemic_Conditions/34024059</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
